Alzamend Neuro, Inc. ATLANTA, May 08, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

Neuro-inclusion is not only relevant at the recruitment stage; it is also important to consider how neurodivergent staff members are being supported after they have joined the organisation. Line ...

KINGSTON, Jamaica — The South East Regional Health Authority (SERHA) is calling for an end to the “politicisation” of the procurement of a $31 million neurosurgical drill for the Bustamante ...

Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's, BD, MDD and PTSD. Our mission is to rapidly develop and market safe ...

KINGSTON, Jamaica — Opposition Spokesperson on Health and Wellness Dr Alfred Dawes on Tuesday announced that he has requested the Auditor General’s Department and the Integrity Commission to ...

READ: Medical Technologies Limited rejects ‘false statements’ by Dawes over $31m neuro drill However, Dr Dawes said whether or not the serial numbers match, there are follow-up questions that ...

il coordinamento e l’interazione tra gli Stati ar-tici, con il coinvolgimento delle comunità indigene. L’obiettivo del Consiglio è garantire alla regione artica «uno sviluppo sostenibile ...

Also Read: EXCLUSIVE: Alzamend Neuro To Start First Phase After losing some value lately, a hammer chart pattern has been formed for Alzamend Neuro (ALZN), indicating that the stock has found support.

Neuro–vascular interactions are the interactions between blood vessels in the brain and their adjacent neurons, and are regulated by complex interactions between endothelial cells, pericytes ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...